Stockscreener 앱 받기
26.98
1.70%
0.45
시간 외 거래:
26.94
-0.04
-0.15%
Viking Therapeutics Inc (VKTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
34.44%
74.57
|
55.47 | 46.24 | 36.56 | 34.05 |
| Operating Income/Loss |
34.44%
-74.57
|
-55.47 | -46.24 | -36.56 | -34.05 |
| Income/Loss From Continuing Operations Before Tax |
43.68%
-65.56
|
-45.63 | -35.42 | -24.94 | -22.25 |
| Income/Loss From Continuing Operations After Tax |
43.68%
-65.56
|
-45.63 | -35.42 | -24.94 | -22.25 |
|
Net Income/Loss
|
43.68%
-65.56
|
-45.63 | -35.42 | -24.94 | -22.25 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.06%
112.13
|
112.07 | 0.775 | 110.91 | 110.39 |
| Diluted Average Shares |
0.06%
112.13
|
112.07 | 0.775 | 110.91 | 110.39 |
| Basic Earnings Per Share |
41.46%
-0.58
|
-0.41 | -0.32 | -0.22 | -0.20 |
| Diluted Earnings Per Share |
41.46%
-0.58
|
-0.41 | -0.32 | -0.22 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
자본화:
|
볼륨(24시간):